Premium accounts now available! Sign up and create a premium account. Read more Scientific Today Close

[Articles] Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial

Journal content Created on 08 Jun 2026 The Lancet

Vanita R Aroda, Melanie J Davies, Jill Maaske, Marcus Millegård, Víctor López Juan, Jens Aberle, Andreea Ciudin, Rory J McCrimmon, Olof Eklund, Judy L Shih, Mikaela Sjostrand, Donna Zarzuela, Julio Rosenstock

Attention!

To access all content shared on our platform and the source link, please sign up for an account. If you already have an account, sign in, or connect with LinkedIn, Google.

Stats

Recommendations n/a n/a positive of 0 vote(s)
Views 34
Comments 0

Comments

There are no comments yet.

Recommendations n/a
Views 34
Comments 0

Recommend? View stats

Content is linked to Lancet Current Issue Feed Lancet Online First Feed

Attention!

Stats

Recommended by

Post a comment

Comments